Literature DB >> 21896498

Solute clearance in CRRT: prescribed dose versus actual delivered dose.

William D Lyndon1, Keith M Wille, Ashita J Tolwani.   

Abstract

BACKGROUND: Substantial efforts have been made toward defining the dose threshold of continuous renal replacement therapy (CRRT) associated with improved survival in critically ill patients with acute kidney injury. Published studies have used prescribed effluent rates, expressed as total effluent volume (TEV) per weight and unit time (mL/kg/h), as a surrogate for dose. The purpose of this study was to compare differences in CRRT dose based on prescribed effluent rate, measured TEV and direct measurement of urea and creatinine clearance.
METHODS: We analyzed data that had been prospectively collected on 200 patients enrolled in a randomized trial comparing survival with a prescribed effluent rate of 20 mL/kg/h (standard dose) to 35 mL/kg/h (high dose) using pre-dilution continuous venovenous hemodiafiltration (CVVHDF). Filters were changed every 72 h. Blood urea nitrogen (BUN), serum creatinine (SCr), effluent urea nitrogen (EUN) and effluent creatinine (ECr) were collected daily. Actual delivered dose was calculated as: (EUN/BUN)*TEV for urea and (ECr/SCr)*TEV for creatinine. Data were available for 165 patients.
RESULTS: In both groups, prescribed dose differed significantly from the measured TEV dose (P < 0.001). In the standard dose group, there was no difference between the measured TEV dose and actual delivered urea and creatinine clearances. However, in the high-dose group, measured TEV dose differed significantly from delivered urea clearance by 7.1% (P < 0.001) and creatinine clearance by 13.9% (P < 0.001).
CONCLUSIONS: Dose based on prescribed effluent rate or measured TEV is a poor substitute for actual CVVHDF creatinine and urea clearance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21896498      PMCID: PMC3289898          DOI: 10.1093/ndt/gfr480

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  24 in total

1.  Effect of blood contact on the transport properties of hemodialysis membranes: a two-layer membrane model.

Authors:  L J Langsdorf; A L Zydney
Journal:  Blood Purif       Date:  1994       Impact factor: 2.614

2.  Protein-membrane interactions during hemodialysis: effects on solute transport.

Authors:  S M Morti; A L Zydney
Journal:  ASAIO J       Date:  1998 Jul-Aug       Impact factor: 2.872

3.  Solute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100 and HF1000 filters.

Authors:  Stéphan Troyanov; Jean Cardinal; David Geadah; Daniel Parent; Sylvie Courteau; Sylvie Caron; Martine Leblanc
Journal:  Nephrol Dial Transplant       Date:  2003-05       Impact factor: 5.992

4.  Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial.

Authors:  C Ronco; R Bellomo; P Homel; A Brendolan; M Dan; P Piccinni; G La Greca
Journal:  Lancet       Date:  2000-07-01       Impact factor: 79.321

5.  Kinetic comparison of different acute dialysis therapies.

Authors:  Zhijie Liao; Weiming Zhang; Peter A Hardy; Churn K Poh; Zhongping Huang; Michael A Kraus; William R Clark; Dayong Gao
Journal:  Artif Organs       Date:  2003-09       Impact factor: 3.094

Review 6.  Dose determinants in continuous renal replacement therapy.

Authors:  William R Clark; Joseph E Turk; Michael A Kraus; Dayong Gao
Journal:  Artif Organs       Date:  2003-09       Impact factor: 3.094

7.  Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial.

Authors:  Catherine S C Bouman; Heleen M Oudemans-Van Straaten; Jan G P Tijssen; Durk F Zandstra; Jozef Kesecioglu
Journal:  Crit Care Med       Date:  2002-10       Impact factor: 7.598

Review 8.  Outcomes in acute renal failure.

Authors:  F Liaño; J Pascual
Journal:  Semin Nephrol       Date:  1998-09       Impact factor: 5.299

Review 9.  Dosing patterns for continuous renal replacement therapy at a large academic medical center in the United States.

Authors:  Ramesh Venkataraman; John A Kellum; Paul Palevsky
Journal:  J Crit Care       Date:  2002-12       Impact factor: 3.425

10.  Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury.

Authors:  Sergio Vesconi; Dinna N Cruz; Roberto Fumagalli; Detlef Kindgen-Milles; Gianpaola Monti; Anibal Marinho; Filippo Mariano; Marco Formica; Mariano Marchesi; Robert René; Sergio Livigni; Claudio Ronco
Journal:  Crit Care       Date:  2009-04-15       Impact factor: 9.097

View more
  11 in total

Review 1.  Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.

Authors:  Yasushi Tsujimoto; Sho Miki; Hiroki Shimada; Hiraku Tsujimoto; Hideto Yasuda; Yuki Kataoka; Tomoko Fujii
Journal:  Cochrane Database Syst Rev       Date:  2021-09-14

2.  Optimal indicator for changing the filter during the continuous renal replacement therapy in intensive care unit patients with acute kidney injury: A crossover randomized trial.

Authors:  Cheng Hang; Li-Jun Liu; Zhao-Yun Huang; Jian-Liang Zhu; Bao-Chun Zhou; Xiao-Zhen Li
Journal:  World J Emerg Med       Date:  2022

3.  Continuous renal replacement therapy versus intermittent hemodialysis in intensive care patients: impact on mortality and renal recovery.

Authors:  Anne-Sophie Truche; Michael Darmon; Sébastien Bailly; Christophe Clec'h; Claire Dupuis; Benoit Misset; Elie Azoulay; Carole Schwebel; Lila Bouadma; Hatem Kallel; Christophe Adrie; Anne-Sylvie Dumenil; Laurent Argaud; Guillaume Marcotte; Samir Jamali; Philippe Zaoui; Virginie Laurent; Dany Goldgran-Toledano; Romain Sonneville; Bertrand Souweine; Jean-Francois Timsit
Journal:  Intensive Care Med       Date:  2016-06-03       Impact factor: 17.440

Review 4.  Quality indicators of continuous renal replacement therapy (CRRT) care in critically ill patients: a systematic review.

Authors:  Oleksa G Rewa; Pierre-Marc Villeneuve; Philippe Lachance; Dean T Eurich; Henry T Stelfox; R T Noel Gibney; Lisa Hartling; Robin Featherstone; Sean M Bagshaw
Journal:  Intensive Care Med       Date:  2016-10-11       Impact factor: 17.440

5.  Timing of renal replacement therapy initiation for acute kidney injury.

Authors:  Alicia Isabel I Fayad; Daniel G Buamscha; Agustín Ciapponi
Journal:  Cochrane Database Syst Rev       Date:  2018-12-18

Review 6.  Nomenclature for renal replacement therapy in acute kidney injury: basic principles.

Authors:  Mauro Neri; Gianluca Villa; Francesco Garzotto; Sean Bagshaw; Rinaldo Bellomo; Jorge Cerda; Fiorenza Ferrari; Silvia Guggia; Michael Joannidis; John Kellum; Jeong Chul Kim; Ravindra L Mehta; Zaccaria Ricci; Alberto Trevisani; Silvio Marafon; William R Clark; Jean-Louis Vincent; Claudio Ronco
Journal:  Crit Care       Date:  2016-10-10       Impact factor: 9.097

7.  Optimal Mode of clearance in critically ill patients with Acute Kidney Injury (OMAKI)--a pilot randomized controlled trial of hemofiltration versus hemodialysis: a Canadian Critical Care Trials Group project.

Authors:  Ron Wald; Jan O Friedrich; Sean M Bagshaw; Karen E A Burns; Amit X Garg; Michelle A Hladunewich; Andrew A House; Stephen Lapinsky; David Klein; Neesh I Pannu; Karen Pope; Robert M Richardson; Kevin Thorpe; Neill K J Adhikari
Journal:  Crit Care       Date:  2012-10-24       Impact factor: 9.097

Review 8.  Intensity of continuous renal replacement therapy for acute kidney injury.

Authors:  Alicia I Fayad; Daniel G Buamscha; Agustín Ciapponi
Journal:  Cochrane Database Syst Rev       Date:  2016-10-04

9.  Quality indicators in continuous renal replacement therapy (CRRT) care in critically ill patients: protocol for a systematic review.

Authors:  Oleksa Rewa; Pierre-Marc Villeneuve; Dean T Eurich; Henry T Stelfox; R T Noel Gibney; Lisa Hartling; Robin Featherstone; Sean M Bagshaw
Journal:  Syst Rev       Date:  2015-07-30

10.  Use of Estimating Equations for Dosing Antimicrobials in Patients with Acute Kidney Injury Not Receiving Renal Replacement Therapy.

Authors:  Linda Awdishu; Ana Isabel Connor; Josée Bouchard; Etienne Macedo; Glenn M Chertow; Ravindra L Mehta
Journal:  J Clin Med       Date:  2018-08-11       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.